Cas:42290-97-1 3-methyl-1-phenylbutan-1-amine manufacturer & supplier

We serve Chemical Name:3-methyl-1-phenylbutan-1-amine CAS:42290-97-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-methyl-1-phenylbutan-1-amine

Chemical Name:3-methyl-1-phenylbutan-1-amine
CAS.NO:42290-97-1
Synonyms:11-Amino-1-isoamyl-benzol;3-METHYL-1-PHENYL-BUTYLAMINE;3-Methyl-1-phenylbutan-1-amine
Molecular Formula:C11H17N
Molecular Weight:163.25900
HS Code:2921499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:237.2ºC at 760 mmHg
Density:0.924g/cm3
Index of Refraction:1.514
PSA:26.02000
Exact Mass:163.13600
LogP:3.43280

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 11-Amino-1-isoamyl-benzol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Methyl-1-phenylbutan-1-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-METHYL-1-PHENYL-BUTYLAMINE Use and application,11-Amino-1-isoamyl-benzol technical grade,usp/ep/jp grade.


Related News: Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 3-methyl-1-phenylbutan-1-amine manufacturer Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. 3-methyl-1-phenylbutan-1-amine supplier Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. 3-methyl-1-phenylbutan-1-amine vendor With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near 3-methyl-1-phenylbutan-1-amine factory The researchers also found that Black women are much less likely to undergo genetic counseling and testing, largely due to differences in physician recommendations or access to care.